Ned Flaxman, UK Country Manager for Krka UK Ltd has been elected as the new Chair of NOAH for 2023/24 at the association’s AGM today. He was previously NOAH’s Vice-Chair.
PetMedix has joined NOAH as an Associate member. Based in Babraham, Cambridge, PetMedix undertakes research and development into monoclonal antibodies for companion animals.
NOAH is delighted to see the changes in the Renters (Reform) Bill which will ban block prohibitions on pets in rental property and pave the way for responsible pet owners to rent with pets.
NOAH's Parliamentary Drop In was a great opportunity to discuss veterinary medicines and the importance of the GB Veterinary Medicines Regulations (VMR) Review.
It's a time to recognise the significant impact that vaccines play in protecting livestock and pets from life-threatening diseases, enabling sustainable farming and production, and improving animal welfare
Look out for #PetPawsitivity tales very soon! #NPM23
NOAH has produced its latest review of the UK animal health sector. The NOAH Annual Review for 2022 and Outlook for 2023 looks at the major opportunities and challenges faced last year and how these were addressed.
Next month, during National Pet Month (NPM), NOAH and UKPetFood will be working together to share help and advice to support pet owners in these challenging times.